Skip to Main Content

WASHINGTON — Medicaid advocates have a lot of opinions about the Trump administration’s rebate rule. Namely, that it makes no sense.

The Trump administration’s controversial proposal to eliminate the drug rebates that pharmacy middlemen and insurers use to negotiate down the price of certain drugs doesn’t stop with that massive change — it proposes eliminating some of the rebates in Medicaid, too. The administration argues that in both programs, the policy will force pharmacies to pass rebates directly to the consumer, meaning lower prices at the pharmacy counter.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.